New Research on Drug-Resistant TB Treatment Presented at ATS 2019

Presentations look at an analysis of nonclinical data regarding drug-resistant TB transmission and a clinical case study of a sterile TB granuloma of the brain

May 21, 2019

Two of TB Alliance's academic collaborators presented findings from scientific research related to drug-resistant forms of tuberculosis at the American Thoracic Society Conference taking place in Dallas, Texas, this week. Details on these presentations are available below:

Measuring the Early Impact on Transmission of New Treatment Regimens for Drug Resistant Tuberculosis - A7387 / 318
May 21, 2019, 9:15 AM -11:15 AM
Access the abstract | View the poster 

Sterile Tuberculous Granuloma of the Brain in a Patient with XDR-TB Treated with Bedaquiline, Pretomanid and Linezolid - A5106 / P1
May 21, 2019, 11:15 AM - 1:00 PM
Access the abstract | View the poster